Aggressive Angiomyxoma of the Cervix: A Unique Entity
Global Journal of Medical and Clinical Case Reports · 2014
DOI: 10.17352/2455-5282.000003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Global Journal of Medical and Clinical Case Reports, 2014. Verfasst von Sujata Siwatch und 2 weiteren Autor:innen. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Aggressive angiomyxoma is a mesenchymal tumour which presents rarely; usually in women in reproductive age group, as a mass in the pelvic tissue. Only exceptionally, has it been seen to originate from the uterus and cervix.
Methods
We present a case of a 23-year-old woman who complained about abdominal pain and excessive vaginal bleeding three days after a spontaneous abortion. Examination revealed a large polyp arising from the cervix. Histopathologic examination of the polypectomy specimen revealed an aggressive angiomyxoma of the cervix. Immunohistochemistry was performed and the tumour was immunopositive for vimentin, desmin and smooth muscle actin. Management options are discussed, in light of need of fertility conservation.
Result
Aggressive angiomyxoma can originate from the mesenchymal tissue of the cervix.
Conclusions
Treatment may be individualized with surgery and hormonal treatment. Long term follow up is recommended.
Zitieren
APA
Siwatch, S., Kundu, R., & Takkar, N. (2014). Aggressive Angiomyxoma of the Cervix: A Unique Entity. Global Journal of Medical and Clinical Case Reports. https://doi.org/10.17352/2455-5282.000003
Vancouver
Siwatch S, Kundu R, Takkar N. Aggressive Angiomyxoma of the Cervix: A Unique Entity. Global Journal of Medical and Clinical Case Reports. 2014. doi:10.17352/2455-5282.000003
BibTeX
@article{Siwatch2014,
author = {Siwatch, Sujata and Kundu, Reetu and Takkar, Navneet},
title = {Aggressive Angiomyxoma of the Cervix: A Unique Entity},
journal = {Global Journal of Medical and Clinical Case Reports},
year = {2014},
doi = {10.17352/2455-5282.000003}
}
EUVIMED